• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine

    2/15/24 11:00:00 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $NAII alert in real time by email

    CARLSBAD, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- CarnoSyn® Brands and parent company Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), today announced its expansion in Brazil with Barentz, creating an exclusive distribution channel for CarnoSyn® beta-alanine throughout the entire Brazilian dietary supplements' market. The new agreement strengthens brand expansion and distribution of a top selling ingredient in sports nutrition—CarnoSyn® beta-alanine—the only scientifically proven and globally patented beta-alanine.

    "This new partnership illustrates our confidence in the Brazilian market and Barentz, who will provide an opportunity for more companies and brands to have access to CarnoSyn®, the safest and most studied beta-alanine available in the world," shared Aaron Starr, Vice President, CarnoSyn® Brands. "We are confident that their experience and expertise will help grow and promote CarnoSyn® Brands in this region. Barentz has worked tirelessly to establish awareness for sports nutrition brands and life science ingredients in Brazil and South America for decades, with a proven track record of success. We look forward to a mutually beneficial business relationship."

    A leading distributor specializing in the life sciences market, Barentz in South America offers high-tech ingredients in various market sectors including dietary supplements, pharmaceuticals, personal care, foods, beverages, and animal nutrition. CarnoSyn® beta-alanine represents the latest innovative ingredient added to their specialty ingredient portfolio for distribution.

    Moses Benzaquen, President Director of Barentz in Brazil, emphasized CarnoSyn®'s exceptional quality, representing the pinnacle of muscle health supplements, "As leaders in the distribution market, we consistently pursue the finest global options, and CarnoSyn® distinguishes itself with proprietary clinical studies, ensuring both efficacy and quality. With the sports nutrition market booming in Brazil, beta-alanine not only addresses athletes' needs but also resonates with consumers pursuing healthier lifestyles. We are confident in the success of our partnership with CarnoSyn® Brands."

    About Barentz

    Barentz is a leading global Life Science ingredients distributor. The company sources branded specialty ingredients from leading manufacturers worldwide. Their team of ingredient experts provide value-added technical support which includes pre-mixing, blending, ingredients formulations and ingredient testing from state-of-the-art customized formulation centers and application laboratories in EMEA, Americas, and Asia-Pacific. Established in 1953, Barentz has operations in more than 70 countries with a strong presence in Europe and North America and a rapidly growing network in South America and Asia-Pacific. In 2018, Barentz, a world leader in products for the Life Science market, arrived in Brazil through a joint venture with Tovani Benzaquen. The company serves more than 2,000 customers throughout the entire Brazilian territory and surrounding countries. Tovani Benzaquen officially became Barentz from 2024 onward, expanding its portfolio to over 3,000 molecules while ensuring the quality of local service. With a turnover of € 2.5 billion, Barentz now employs around 2,600 people worldwide and serves over 25,000 customers. For more information, visit: www.barentz.com.

    About CarnoSyn® Brands:

    CarnoSyn® Brands feature two clinically studied, patented ingredients available exclusively from Natural Alternatives International, Inc.: CarnoSyn® instant release beta-alanine powder and SR CarnoSyn® sustained release beta-alanine tablets. In 2019, CarnoSyn® beta-alanine successfully obtained NDI status from the FDA and received Self-Affirmed GRAS (Generally Recognized as Safe) status. SR CarnoSyn®, an advanced delivery form of CarnoSyn®, received GRAS affirmation in 2017. The GRAS affirmation allows NAI to broaden their product offerings within the food and beverage industries, including medical and other fortified food products. For more information about CarnoSyn® in sports nutrition, please visit: www.carnosyn.com. For information on SR CarnoSyn® in healthy aging and wellness, visit www.srcarnosyn.com.

    About NAI:

    NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI's comprehensive partnership approach offers a wide range of innovative nutritional products and services to clients including scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. For more information about NAI, please visit www.nai-online.com.

    Contact:

    Renee Michaelson

    Director of Global Marketing

    NAI/CarnoSyn® Brands

    (760) 736-7700

    [email protected]



    Get the next $NAII alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NAII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NAII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO/Chairman Ledoux Mark A bought $3,474 worth of shares (1,250 units at $2.78), increasing direct ownership by 0.79% to 160,221 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    3/6/26 7:36:05 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    CEO/Chairman Ledoux Mark A bought $2,820 worth of shares (1,000 units at $2.82), increasing direct ownership by 0.63% to 158,971 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    3/3/26 7:23:35 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    CEO/Chairman Ledoux Mark A bought $3,528 worth of shares (1,250 units at $2.82), increasing direct ownership by 0.80% to 157,971 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    2/27/26 5:18:48 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results

    CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.6 million, or $0.42 per diluted share, on net sales of $34.8 million for the second quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the second quarter of the prior fiscal year. Net sales during the three months ended December 31, 2025, increased $0.7 million, or 2%, to $34.8 million as compared to $34.1 million recorded in the comparable prior year period. During the same period, private-label contract m

    2/13/26 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces 2026 Q1 Results

    CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $0.3 million, or $0.05 per diluted share, on net sales of $37.7 million for the first quarter of fiscal year 2026 compared to a net loss of $2.0 million, or $0.33 per diluted share, in the first quarter of the prior fiscal year. Net sales during the three months ended September 30, 2025, increased $4.6 million, or 13.8%, to $37.7 million as compared to $33.2 million recorded in the comparable prior year period. During the same period, private-label contract m

    11/12/25 4:44:13 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results

    CARLSBAD, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $7.2 million, or ($1.20) per diluted share, on net sales of $33.9 million for the fourth quarter of fiscal year 2025 compared to a net loss of $1.9 million, or ($0.32) per diluted share, in the fourth quarter of the prior fiscal year. Our net loss for the fourth quarter of fiscal 2025 included non-recurring non-cash charges of $1.4 million related to the settlement of a litigation matter and a $4.8 million valuation allowance against our net deferred tax asse

    9/23/25 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    SEC Filings

    View All

    Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Filer)

    3/20/26 4:30:38 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 10-Q filed by Natural Alternatives International Inc.

    10-Q - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Filer)

    2/13/26 4:17:10 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Natural Alternatives International Inc.

    SCHEDULE 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    1/21/26 1:21:12 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Natural Alternatives International Inc.

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    3/10/26 8:47:12 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Natural Alternatives International Inc.

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    3/10/26 8:47:40 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    President, COO, & Sec. Wolf Kenneth covered exercise/tax liability with 5,151 shares and was granted 15,000 shares, increasing direct ownership by 7% to 141,831 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    3/10/26 8:48:09 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Financials

    Live finance-specific insights

    View All

    Natural Alternatives International, Inc. Announces 2022 Q1 Results

    CARLSBAD, Calif., Nov. 9, 2021 /PRNewswire/ -- -Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $3.3 million, or $0.51 per diluted share, on net sales of $38.3 million for the first quarter of fiscal year 2022 compared to net income of $2.3 million, or $0.35 per diluted share, in the first quarter of the prior fiscal year.  Net sales during the three months ended September 30, 2021 decreased $1.4 million, or 3.5%, to $38.3 million as compared to $39.7 million recorded in the comparable prior year period.  During the same period, private-label contract man

    11/9/21 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces 2021 Q3 and YTD Results

    CARLSBAD, Calif., May 13, 2021 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $1.9 million, or $0.30 per diluted share, on net sales of $46.3 million for the third quarter of fiscal year 2021 compared to a net loss of $4.0 million, or $0.61 per diluted share, in the third quarter of the prior fiscal year.  Our results for the third quarter of fiscal 2020 included the negative impact of a $4.3 million accounts receivable and inventory reserve related to a former customer, which was not repeated in the third quarter of fiscal 2021.  Net s

    5/13/21 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Leadership Updates

    Live Leadership Updates

    View All

    Natural Alternatives International Appoints New VP of Global Sales

    CARLSBAD, Calif., July 25, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII) ), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced that sales executive Shane Conti has joined the company as the Vice President of Global Sales and will be a key driver of global expansion and growth. Over the course of his 25 plus year career in the domestic and international nutritional supplement industry, Conti has established a proven track record of success in building new business within multiple markets. "Shan

    7/25/23 9:00:00 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    NATURAL ALTERNATIVES INTERNATIONAL APPOINTS AARON STARR VICE PRESIDENT FOR CARNOSYN® BRANDS

    CARLSBAD, Calif., April 21, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), an international leader in custom contract nutritional supplement manufacturing for over four decades, announced Aaron Starr has been promoted to Vice President of CarnoSyn® Brands. In his new role, Starr will be responsible for the leadership of business teams and for overseeing operational performance and the advancement of CarnoSyn® Brands. "I am pleased to announce Aaron Starr has been named Vice President of CarnoSyn® Brands," said Kenneth Wolf, President and Chief Operating Officer, Natural Alternatives International. "Aaron has been a valued member of our team for many year

    4/21/22 5:00:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Neptune Wellness Appoints Randy Weaver as Interim Chief Financial Officer and Retains Dr. Toni Rinow as Chief Operating Officer

    LAVAL, QC, Sept. 27, 2021 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT) (TSX:NEPT), a diversified and fully integrated health and wellness company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced the appointment of Randy Weaver as Interim Chief Financial Officer while retaining Dr. Toni Rinow as Chief Operating Officer. Mr. Weaver joins Neptune as Interim Chief Financial Officer with a successful track record of leading numerous CPG companies as a senior executive, bringing the knowledge and e

    9/27/21 7:30:00 AM ET
    $NAII
    $NEPT
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $NAII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/13/24 10:37:08 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/9/24 9:59:14 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/5/24 8:25:38 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care